SpringerLink
Log in

Colorectal cancer

Mutations linked to chemotherapy resistance in colorectal cancer

  • Research Highlight
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • van de Haar, J. et al. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. Nat. Med. 29, 605–614 (2023)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Gastroenterology & Hepatology http://www.nature.com/nrgastro/

    Ian Fyfe

Authors
  1. Ian Fyfe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Fyfe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fyfe, I. Mutations linked to chemotherapy resistance in colorectal cancer. Nat Rev Gastroenterol Hepatol 20, 269 (2023). https://doi.org/10.1038/s41575-023-00772-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-023-00772-5

  • Springer Nature Limited

This article is cited by

Search

Navigation